Company intelligence / Profile preview

Harrow

Nashville, Tennessee, United Statesharrowinc.gcs-web.com ↗

Ownership: Public · HROW
Employees: ~382
Development stage: Commercial

Overview

Harrow has a broad commercial portfolio of FDA-approved and compounded ophthalmic pharmaceuticals for a range of acute and chronic eye diseases. The company’s products are widely used in the U.S. by ophthalmologists and retinal specialists for both surgical procedures and ongoing care. Revenue growth has been strong in recent years as the company expands its product offerings[1][5][6].

Therapeutic areas: OphthalmologyImmunologyInfectious Diseases
Modalities: Small molecules (ophthalmic drugs)Compounded formulations
Industry: Biotech

Drug pipeline

9 assets

Imprimis Dropless

8 more assets in the full pipeline.

Request access →

Partnerships

EyePoint Pharmaceuticals partnership to sell Dexycu steroid product through ImprimisRx[4]No other major partnerships explicitly listed in results.

Financials

Market cap: $1.4B
Total revenue: $70.7M
Enterprise value: $1.6B

Beyond the preview

Go deeper on Harrow.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Harrow.

Explore the full profile